α1‐antitrypsin inhibits angiogenesis and tumor growth
Open Access
- 12 August 2004
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 112 (6), 1042-1048
- https://doi.org/10.1002/ijc.20494
Abstract
Disturbances of the ratio between angiogenic inducers and inhibitors in tumor microenvironment are the driving force behind angiogenic switch critical for tumor progression. Angiogenic inhibitors may vary depending on organismal age and the tissue of origin. We showed that α1-antitrypsin (AAT), a serine protease inhibitor (serpin) is an inhibitor of angiogenesis, which induced apoptosis and inhibited chemotaxis of endothelial cells. S- and Z-type mutations that cause abnormal folding and defective serpin activity abrogated AAT antiangiogenic activity. Removal of the C-terminal reactive site loop had no effect on its angiostatic activity. Both native AAT and AAT truncated on C-terminus (AATΔ) inhibited neovascularization in the rat cornea and delayed the growth of subcutaneous tumors in mice. Treatment with native AAT and truncated AATΔ, but not control vehicle reduced tumor microvessel density, while increasing apoptosis within tumor endothelium. Comparative analysis of the human tumors and normal tissues of origin showed correlation between reduced local α1-antitrypsin expression and more aggressive tumor growth.Keywords
This publication has 34 references indexed in Scilit:
- Antiangiogenic Activity of the Cleaved Conformation of the Serpin AntithrombinScience, 1999
- Inhibitory Mechanism of Serpins MOBILITY OF THE C-TERMINAL REGION OF THE REACTIVE-SITE LOOPPublished by Elsevier BV ,1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Acute phase proteins and recombinant IL-2 therapy: prediction of response and survival in patients with colorectal cancerClinical and Experimental Immunology, 1995
- Effects of Proteinase Inhibitors on Polymorphonuclear Neutrophil Polarization.The Tohoku Journal of Experimental Medicine, 1991
- PECAM-1 (CD31) Cloning and Relation to Adhesion Molecules of the Immunoglobulin Gene SuperfamilyScience, 1990
- Molecular basis of alpha-1-antitrypsin deficiencyAmerican Journal Of Medicine, 1988
- Replacement Therapy for Alpha1-Antitrypsin Deficiency Associated with EmphysemaNew England Journal of Medicine, 1987
- Risk of Cirrhosis and Primary Liver Cancer in Alpha1-Antitrypsin DeficiencyNew England Journal of Medicine, 1986